The client had received a diagnosis of Stage 3 colorectal cancer and was being treated within the NHS with standard chemotherapy protocols. However, he had been contacted by a clinic in Germany offering a "personalised immunotherapy protocol" that they claimed had superior outcomes to conventional treatment. The cost was 40,000 GBP out of pocket, and the timeframe was urgent. The clinic's marketing material suggested that NHS treatment was outdated and that this private approach was his best chance.
He was frightened, confused, and under pressure to decide quickly.
We conducted a systematic literature review examining the evidence base for both standard NHS colorectal cancer protocols and the specific immunotherapy approach being promoted. We reviewed the clinic's claims against current NICE guidance, ASCO recommendations, and peer-reviewed oncology literature from 2023-2025.
We examined outcomes data for Stage 3 colorectal cancer across both treatment modalities. We assessed the evidence quality, sample sizes, and follow-up periods. We also reviewed the institutional credentials and research publication record of the German clinic.
The analysis revealed that the German clinic's immunotherapy protocol, while not harmful, had not demonstrated superior outcomes to standard NHS chemoradiation in peer-reviewed publications. The claims being made were based on preliminary data from a small cohort without long-term follow-up. Standard NHS protocols for Stage 3 colorectal cancer have 5-year survival rates of approximately 65-70% with robust evidence. The German protocol's marketing claims, while not technically false, were overstated relative to the current evidence base.
Additionally, the clinic's pressure to decide quickly, and the framing of NHS treatment as inferior, were red flags for exploitative marketing rather than evidence-based medicine.
Patient proceeded with NHS treatment with informed confidence. Full understanding of evidence base for his treatment approach. Avoided 40,000 GBP unnecessary expenditure on unproven protocol. Anxiety reduced through clear evidence-based explanation. Proceeding with standard chemotherapy with improved psychological resilience.
All case studies are anonymised composites based on real scenarios. Details changed to protect confidentiality. Individual outcomes vary.
Facing a major treatment decision and unsure which path is right?
Begin a Private Inquiry